Peter H. Jones

10.2k citations

138 papers · 7.1k indexed · 2 hit papers · h-index 41

Impact in

Endocrinology, Diabetes and Metabolism top 0.5%
- Diabetes, Cardiovascular Risks, and Lipoproteins
Surgery top 0.5%
- Lipoproteins and Cardiovascular Health

Papers in

Endocrinology, Diabetes and Metabolism 57
- Diabetes, Cardiovascular Risks, and Lipoproteins 52
Surgery 104
- Lipoproteins and Cardiovascular Health 91

Co-authors: Michael H. Davidson Harold Bays Christie M. Ballantyne James M. McKenney Evan A. Stein Valerie A. Cain James W. Blasetto Elinor Miller
Journals: Journal of clinical lipidology (23 papers)The American Journal of Cardiology (19 papers)Atherosclerosis (7 papers)Current Atherosclerosis Reports (6 papers)Journal of Medicinal Chemistry (5 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Peter H. Jones

135 papers receiving 6.7k citations

Hit Papers

align trajectories log scale

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report 2015 · 582 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Journal of clinical lipidology
2003 The American Journal of Cardiology

Peers

Countries citing papers authored by Peter H. Jones

Since Specialization

Citations

This map shows the geographic impact of Peter H. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter H. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter H. Jones more than expected).

Fields of papers citing papers by Peter H. Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter H. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter H. Jones. The network helps show where Peter H. Jones may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter H. Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter H. Jones Line = papers co-authored together Peter H. Jones links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Association of low-density lipoprotein pattern with mortality after myocardial infarction: Insights from the TRIUMPH study Journal of clinical lipidology ·Yashashwi Pokharel, Yuanyuan Tang, Bhaskar Bhardwaj, Krishna Patel, Mohammed Qintar, James H. O’Keefe, Krishnaji Kulkarni, Peter H. Jones, Seth S. Martin, Salim S. Virani, John A. Spertus	2017	14
2	Safety of Alirocumab (A PCSK9 Monoclonal Antibody) from 14 Randomized Trials The American Journal of Cardiology ·Peter H. Jones, Harold Bays, Umesh Chaudhari, Robert Pordy, Christelle Lorenzato, Kathryn Miller, Jennifer G. Robinson	2016	73
3	POOLED SAFETY AND ADVERSE EVENTS IN NINE RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 AND 3 CLINICAL TRIALS OF ALIROCUMAB Journal of the American College of Cardiology ·Peter H. Jones, Harold Bays, Umesh Chaudhari, Robert Pordy, Christelle Lorenzato, Kathryn Miller, J.C. Robinson	2015	7
4	Unilateral transverse cordotomy for bilateral abductor vocal fold immobility The Journal of Laryngology & Otology ·Jonathan M. Bernstein, Susan Jones, Peter H. Jones	2012	10
5	Effects of Maximal Atorvastatin and Rosuvastatin Treatment on Markers of Glucose Homeostasis and Inflammation The American Journal of Cardiology ·Nuntakorn Thongtang, Masumi Ai, Seiko Otokozawa, H. L., Bela F. Asztalos, Katsuyuki Nakajima, Evan A. Stein, Peter H. Jones, Ernst J. Schaefer	2011	62
6	Long-Term Efficacy of Adding Fenofibric Acid to Moderate-Dose Statin Therapy in Patients with Persistent Elevated Triglycerides Cardiovascular Drugs and Therapy ·Christie M. Ballantyne, Peter H. Jones, Maureen T. Kelly, Carolyn M. Setze, Rodrigo Sebastián Murillo Ramos, Kamlesh M. Thakker, James C. Stolzenbach	2011	12
7	Retrospective Comparison of the Effectiveness of a Fenofibrate 145 mg Formulation Compared with the Standard 160 mg Tablet Clinical Drug Investigation ·Michael H. Davidson, Peter H. Jones	2008	6
8	Effects of Maximal Doses of Atorvastatin Versus Rosuvastatin on Small Dense Low-Density Lipoprotein Cholesterol Levels The American Journal of Cardiology ·Masumi Ai, Seiko Otokozawa, Bela F. Asztalos, Katsuyuki Nakajima, Evan A. Stein, Peter H. Jones, Ernst J. Schaefer	2007	52
9	Complementary Therapy to Target LDL Cholesterol: The Role of the Ezetimibe/Simvastatin Combination SHILAP Revista de lepidopterología ·Betty G. Danzi, Peter H. Jones	2006	2
10	The effects of plant sterols on serum lipid profiles of laying hens. Mahmoud Raeini−Sarjaz, Konan Gabriel N'GUESSAN, Zeng Qing-ming, Zahid Ansari, Peter H. Jones	2006	3
11	Effective use of combination lipid therapy Current Cardiology Reports ·Abu R. Vasudevan, Peter H. Jones	2005	11
12	Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of ‘systemic steatosis’ Current Opinion in Lipidology ·Ashok Balasubramanyam, Rajagopal V. Sekhar, Farook Jahoor, Peter H. Jones, Henry J. Pownall	2004	52
13	Statins as the cornerstone of drug therapy for dyslipidemia: monotherapy and combination therapy options American Heart Journal ·Peter H. Jones	2004	23
14	Statin therapies for elevated lipid levels compared across dose ranges to rosuvastatin: Low-density lipoprotein cholesterol and high-density lipoprotein cholesterol results Journal of the American College of Cardiology ·Peter H. Jones	2003	2
15	Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial Current Medical Research and Opinion ·James M. McKenney, Peter H. Jones, Maciej Adamczyk, Valerie A. Cain, Brian Bryzinski, James W. Blasetto, (unknown)	2003	133
16	Treatment of patients with mild to moderate hypercholesterolemia: Lipoprotein and Coronary Atherosclerosis Study (LCAS) Christie M. Ballantyne, J. Alan Herd, Jeffrey Schein, Peter H. Jones, John A. Farmer, Antonio M. Gotto	1998	2
17	Effectiveness of Atorvastatin for Reducing Low-Density Lipoprotein Cholesterol to National Cholesterol Education Program Treatment Goals The American Journal of Cardiology ·Michael H. Davidson, David A. Lane, Stuart Weiss, Sherwyn Schwartz, Paul-J. Lupien, Peter H. Jones, Harry Haber, Donald M. Black	1997	18
18	Physician Education in Hyperlipidemia Management: The Impact on Collaboration Southern Medical Journal ·Darlene Lessa Machado, David J. Hyman, Elizabeth Jones, Lynne W. Scott, Peter H. Jones	1997	4
19	Lovastatin and simvastatin prevention studies The American Journal of Cardiology ·Peter H. Jones	1990	17
20	Alpha chain unsaturated derivatives of misoprostol Prostaglandins ·Paul W. Collins, Alan F. Gasiecki, Richard M. Weier, Steven W. Kramer, Peter H. Jones, Gary W. Gullikson, Robert G. Bianchi, R. F. Bauer	1987	2

About Peter H. Jones

Peter H. Jones is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Cancer Research, Geriatrics and Gerontology and Economics and Econometrics, having authored 138 papers that have together received 7.1k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (91 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (52 papers), Cancer, Lipids, and Metabolism (26 papers), Health Systems, Economic Evaluations, Quality of Life (19 papers), Pharmaceutical Economics and Policy (14 papers), Diet and metabolism studies (9 papers), Lipid metabolism and disorders (8 papers) and Adipokines, Inflammation, and Metabolic Diseases (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.3k citations), Surgery (4.4k citations), Cancer Research (1.0k citations), Cardiology and Cardiovascular Medicine (1.2k citations) and Economics and Econometrics (1.3k citations). Peter H. Jones has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Michael H. Davidson, Harold Bays, Christie M. Ballantyne, James M. McKenney, Evan A. Stein, Valerie A. Cain, James W. Blasetto, Elinor Miller, Antonio M. Gotto and W. Virgil Brown. Their work appears in journals such as Journal of clinical lipidology, The American Journal of Cardiology, Atherosclerosis, Current Atherosclerosis Reports and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact